Phase III Tekturna Diabetes Data Could Further Differentiate Drug From Competing Hypertension Products

Development partner Speedel tells “The Pink Sheet” DAILY that hypertension treatments “need to offer something more than blood pressure lowering.”

More from Archive

More from Pink Sheet